LGT Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

LGT Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$91	–	655
2025 Q2	$91	Buy	+1	New	+$97	﹤0.01%	602

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LGT Financial Advisors's ZBH Position: Q3 2025 in Review

LGT Financial Advisors sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 1 share — an estimated $91 sold.

LGT Financial Advisors first reported a position in ZBH in Q2 2025 and held it in 1 quarter. The position peaked at $91 in Q2 2025. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

LGT Financial Advisors reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
LGT Financial Advisors sold 1 Zimmer Biomet share in Q3 2025, an estimated $91.
LGT Financial Advisors first reported a position in Zimmer Biomet in Q2 2025 and held it in 1 quarter.
LGT Financial Advisors's Zimmer Biomet position peaked at $91 in Q2 2025.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.